These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25257978)

  • 61. Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2005 Nov; 183(1):1-12. PubMed ID: 16160876
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gender differences in self-reported withdrawal symptoms and reducing or quitting smoking three years later: A prospective, longitudinal examination of U.S. adults.
    Weinberger AH; Platt JM; Shuter J; Goodwin RD
    Drug Alcohol Depend; 2016 Aug; 165():253-9. PubMed ID: 27350655
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Extended treatment for cigarette smoking cessation: a randomized control trial.
    Laude JR; Bailey SR; Crew E; Varady A; Lembke A; McFall D; Jeon A; Killen D; Killen JD; David SP
    Addiction; 2017 Aug; 112(8):1451-1459. PubMed ID: 28239942
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia.
    Evins AE; Cather C; Deckersbach T; Freudenreich O; Culhane MA; Olm-Shipman CM; Henderson DC; Schoenfeld DA; Goff DC; Rigotti NA
    J Clin Psychopharmacol; 2005 Jun; 25(3):218-25. PubMed ID: 15876899
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Coping with urges to smoke: what is a clinician to do?
    Modesto-Lowe V; Chmielewska A
    Conn Med; 2013 May; 77(5):289-94. PubMed ID: 23777042
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Behavioral activation and smoking cessation outcomes: The role of depressive symptoms.
    Martínez-Vispo C; López-Durán A; Senra C; Rodríguez-Cano R; Fernández Del Río E; Becoña E
    Addict Behav; 2020 Mar; 102():106183. PubMed ID: 31809878
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
    Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
    JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia.
    Tidey JW; Rohsenow DJ; Kaplan GB; Swift RM; Reid N
    Psychopharmacology (Berl); 2011 Sep; 217(2):279-87. PubMed ID: 21475970
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative dynamics of four smoking withdrawal symptom scales.
    Javitz HS; Lerman C; Swan GE
    Addiction; 2012 Aug; 107(8):1501-11. PubMed ID: 22321019
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Smoking Cessation in Individuals With Serious Mental Illness: A Randomized Controlled Trial of Two Psychosocial Interventions.
    Bennett ME; Brown CH; Li L; Himelhoch S; Bellack A; Dixon L
    J Dual Diagn; 2015; 11(3-4):161-73. PubMed ID: 26457385
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Feasibility and Quit Rates of the Tobacco Status Project: A Facebook Smoking Cessation Intervention for Young Adults.
    Ramo DE; Thrul J; Chavez K; Delucchi KL; Prochaska JJ
    J Med Internet Res; 2015 Dec; 17(12):e291. PubMed ID: 26721211
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Relationship of childhood trauma to depression and smoking outcomes in pregnant smokers.
    Blalock JA; Minnix JA; Mathew AR; Wetter DW; McCullough JP; Cinciripini PM
    J Consult Clin Psychol; 2013 Oct; 81(5):821-30. PubMed ID: 23750463
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Testing the efficacy of yoga as a complementary therapy for smoking cessation: design and methods of the BreathEasy trial.
    Bock BC; Rosen RK; Fava JL; Gaskins RB; Jennings E; Thind H; Carmody J; Dunsiger SI; Gidron N; Becker BM; Marcus BH
    Contemp Clin Trials; 2014 Jul; 38(2):321-32. PubMed ID: 24937018
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Stress-related increases in risk taking and attentional failures predict earlier relapse to smoking in young adults: A pilot investigation.
    Schepis TS; Tapscott BE; Krishnan-Sarin S
    Exp Clin Psychopharmacol; 2016 Apr; 24(2):110-9. PubMed ID: 26901590
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of an intensive depression-focused intervention for smoking cessation in pregnancy.
    Cinciripini PM; Blalock JA; Minnix JA; Robinson JD; Brown VL; Lam C; Wetter DW; Schreindorfer L; McCullough JP; Dolan-Mullen P; Stotts AL; Karam-Hage M
    J Consult Clin Psychol; 2010 Feb; 78(1):44-54. PubMed ID: 20099949
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The moderating role of experiential avoidance in the relationships between internal distress and smoking behavior during a quit attempt.
    Minami H; Bloom EL; Reed KM; Hayes SC; Brown RA
    Psychol Addict Behav; 2015 Jun; 29(2):400-7. PubMed ID: 25347023
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Positive Affect as a Predictor of Smoking Cessation and Relapse: Does It Offer Unique Predictive Value among Depressive Symptom Domains?
    Heffner JL; Mull KE; McClure JB; Bricker JB
    Subst Use Misuse; 2018 May; 53(6):980-988. PubMed ID: 29161212
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Stress and quitting among African American smokers.
    Manning BK; Catley D; Harris KJ; Mayo MS; Ahluwalia JS
    J Behav Med; 2005 Aug; 28(4):325-33. PubMed ID: 16049631
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identifying mechanisms that link pain to smoking relapse during a quit attempt.
    Alexander AC; Waring JJC; Hébert ET; Ra CK; Rangu N; Kendzor DE; Businelle MS
    Psychol Addict Behav; 2021 Feb; 35(1):52-61. PubMed ID: 33719473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.